UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

Oncogene, 2014-05, Vol.33 (19), p.2423-2431

2014

Volltextzugriff (PDF)

PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review

International journal of molecular sciences, 2019-10, Vol.20 (19), p.4886

2019

Volltextzugriff (PDF)

Predicting Model of Biochemical Recurrence of Prostate Carcinoma (PCa-BCR) Using MR Perfusion-Weighted Imaging-Based Radiomics

Technology in cancer research & treatment, 2023-01, Vol.22, p.15330338231166766-15330338231166766

2023

Volltextzugriff (PDF)

Evaluation Expression COX-2 in Prostatic Carcinoma by PCR and Immunohistochemistry and Its Relationship with Gleason Score

Asian Pacific journal of cancer biology, 2021-05, Vol.6 (2), p.105-109

2021

Volltextzugriff (PDF)

Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

Cancers, 2021-06, Vol.13 (12), p.3095

2021

Volltextzugriff (PDF)

The differential diagnostic value of dual-phase 18F-DCFPyL PET/CT in prostate carcinoma: methodological issues

Prostate cancer and prostatic diseases, 2023-03, Vol.26 (1), p.213-213

2023

Volltextzugriff (PDF)

Investigating PSMA differential expression in canine uroepithelial carcinomas to aid disease-based stratification and guide therapeutic selection

BMC veterinary research, 2022-12, Vol.18 (1), p.441-9, Article 441

2022

Volltextzugriff (PDF)

ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63

The Prostate, 2018-09, Vol.78 (12), p.896-904

2018

Volltextzugriff (PDF)

Basal Cell Carcinoma of Prostate With MSMB–NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report

International journal of surgical pathology, 2021-12, Vol.29 (8), p.850-855

2021

Volltextzugriff (PDF)

Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma

Biomedicine & pharmacotherapy, 2019-09, Vol.117, p.109109-109109, Article 109109

2019

Volltextzugriff (PDF)

Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17

Cancer management and research, 2021-01, Vol.13, p.2773-2783

2021

Volltextzugriff (PDF)

Hepatoid prostatic carcinoma with adrenal metastasis and novel genetic alterations

Diagnostic cytopathology, 2022-11, Vol.50 (11), p.E310-E314

2022

Volltextzugriff (PDF)

New azole derivatives of [17(20)E]-21-norpregnene: Synthesis and inhibition of prostate carcinoma cell growth

Steroids, 2019-07, Vol.147, p.10-18

2019

Volltextzugriff (PDF)

Retraction: SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas

PloS one, 2020-08, Vol.15 (8), p.e0237487-e0237487

2020

Volltextzugriff (PDF)

Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy

Scientific reports, 2024-06, Vol.14 (1), p.14868-8, Article 14868

2024

Volltextzugriff (PDF)

Modelling and optimisation of treatment parameters in high-dose-rate mono brachytherapy for localised prostate carcinoma using a multilayer artificial neural network and a genetic algorithm: Pilot study

Computers in biology and medicine, 2020-11, Vol.126, p.104045, Article 104045

2020

Volltextzugriff (PDF)

Study the Expression of CD10 in Prostate Carcinoma and its Correlation with Various Clinicopathological Parameters

Iranian Journal of Pathology, 2019, Vol.14 (2), p.135-141

2019

Volltextzugriff (PDF)

Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations

Cytokine (Philadelphia, Pa.), 2015-07, Vol.74 (1), p.117-122

2015

Volltextzugriff (PDF)

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Cancer, 2004-04, Vol.100 (7), p.1397-1405

2004

Volltextzugriff (PDF)

Intraductal Carcinoma of the Prostate versus Simulants: A Differential Diagnosis Growing in Clinical Impact

Cancers, 2024-03, Vol.16 (6), p.1097

2024

Volltextzugriff (PDF)

Atrophic and Microcystic Limited Prostatic Adenocarcinomas

International journal of surgical pathology, 2020-09, Vol.28 (6), p.584-589

2020

Volltextzugriff (PDF)

Prostate adenocarcinoma of secretory type with wide expression of p63 and negativity of the basal marker Ck5/6: Rare subtype of adenocarcinoma of secretory origin and to be differentiated from basal cell carcinoma. Review of literature

Rare tumors, 2020, Vol.12, p.2036361320971948

2020

Volltextzugriff (PDF)

Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives

Current issues in molecular biology, 2023-03, Vol.45 (4), p.2767-2780

2023

Volltextzugriff (PDF)

Molecular Alterations in Intraductal Carcinoma of the Prostate

Cancers, 2023-11, Vol.15 (23), p.5512

2023

Volltextzugriff (PDF)

Cathepsin K Expression in Castration-Resistant Prostate Carcinoma: A Therapeutical Target for Patients at Risk for Bone Metastases

The International journal of biological markers, 2017-04, Vol.32 (2), p.243-247

2017

Volltextzugriff (PDF)

1 – 25 von 21.877

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19.371)
Mit Volltextzugriff
(16.529)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(17.221)
Humans
(17.107)
Life Sciences & Biomedicine
(15.971)
Male
(14.429)
Biological And Medical Sciences
(7.395)
Medical Sciences
(7.228)
Aged
(7.158)
Oncology
(6.717)
Middle Aged
(6.684)
Prostate Cancer
(6.539)
Nephrology. Urinary Tract Diseases
(5.924)
Urinary Tract. Prostate Gland
(5.811)
Tumors Of The Urinary System
(5.732)
Female
(5.489)
Prostatic Neoplasms - Pathology
(4.816)
Tumors
(4.739)
Prostate
(4.631)
Urology & Nephrology
(4.414)
Cancer
(3.246)
Adult
(3.101)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(1.291)
Plos One
(968)
Cancer
(875)
International Journal Of Radiation Oncology, Biology, Physics
(632)
European Urology
(571)
Urology
(539)
The Prostate
(395)
Bju International
(377)
British Journal Of Urology
(315)
Cancers
(268)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(76)
... seit 30 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review

Predicting Model of Biochemical Recurrence of Prostate Carcinoma (PCa-BCR) Using MR Perfusion-Weighted Imaging-Based Radiomics

Evaluation Expression COX-2 in Prostatic Carcinoma by PCR and Immunohistochemistry and Its Relationship with Gleason Score

Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

The differential diagnostic value of dual-phase 18F-DCFPyL PET/CT in prostate carcinoma: methodological issues

Investigating PSMA differential expression in canine uroepithelial carcinomas to aid disease-based stratification and guide therapeutic selection

ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63

Basal Cell Carcinoma of Prostate With MSMB–NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report

Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma

Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17

Hepatoid prostatic carcinoma with adrenal metastasis and novel genetic alterations

New azole derivatives of [17(20)E]-21-norpregnene: Synthesis and inhibition of prostate carcinoma cell growth

Retraction: SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas

Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy

Modelling and optimisation of treatment parameters in high-dose-rate mono brachytherapy for localised prostate carcinoma using a multilayer artificial neural network and a genetic algorithm: Pilot study

Study the Expression of CD10 in Prostate Carcinoma and its Correlation with Various Clinicopathological Parameters

Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Intraductal Carcinoma of the Prostate versus Simulants: A Differential Diagnosis Growing in Clinical Impact

Atrophic and Microcystic Limited Prostatic Adenocarcinomas

Prostate adenocarcinoma of secretory type with wide expression of p63 and negativity of the basal marker Ck5/6: Rare subtype of adenocarcinoma of secretory origin and to be differentiated from basal cell carcinoma. Review of literature

Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives

Molecular Alterations in Intraductal Carcinoma of the Prostate

Cathepsin K Expression in Castration-Resistant Prostate Carcinoma: A Therapeutical Target for Patients at Risk for Bone Metastases

Suchergebnisse filtern